Novelix Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Particulars | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 |
---|---|---|---|---|---|
Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Current Ratio | 106.13 | 128.43 | 315.33 | 214.00 | 77.10 |
Fixed Assets | 3.19 | 0.83 | 0.60 | 0.85 | 0.58 |
Inventory | 4.51 | 2.84 | 3.56 | 7.94 | 16.67 |
Debtors | 45.30 | 13.24 | 14.63 | 15.41 | 1.35 |
Interest Cover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM (%) | 0.44 | 0.00 | -107.19 | -243.51 | 12.00 |
PBITM (%) | -0.44 | -3.13 | -112.23 | -249.62 | 6.67 |
PBDTM (%) | 0.44 | 0.00 | -107.19 | -243.51 | 12.00 |
CPM (%) | 0.44 | 0.00 | -107.19 | -243.51 | 11.33 |
APATM (%) | -0.44 | -3.13 | -112.23 | -249.62 | 6.00 |
ROCE (%) | -0.24 | 0.00 | 0.00 | 0.00 | 0.83 |
RONW (%) | -0.24 | 0.00 | 0.00 | 0.00 | 0.75 |